Document is current

Article History

Accepted: 3 February 2025

First Online: 6 March 2025

Declarations

:

: The study was funded by Chongqing Dikang Erle Pharmaceutical Co. Ltd.

: DZ and WZ were Chongqing Dikang Erle Pharmaceutical Co. Ltd. employees at the time the study was conducted. All the authors have no competing interests in relation to the work described.

: RC and ZJ designed the study. QL, SH, and YM recruited patients and were responsible for the informed consent form signing process. SH and YM followed up with patients. QL, DZ, and WZ conducted the data analysis. QL and SH wrote the first draft of the manuscript, and RC and ZJ edited the manuscript. RC and ZJ are the guarantors of this work and, as such, had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

: Ethics Committee of Peking Union Medical College Hospital (Approval number HS2020053).

: Written, informed consent was obtained from all participants.

: Not applicable.

: Not applicable.